Cargando…
Born to be Alive: A Role for the BCL-2 Family in Melanoma Tumor Cell Survival, Apoptosis, and Treatment
The global incidence of melanoma has dramatically increased during the recent decades, yet the advancement of primary and adjuvant therapies has not kept a similar pace. The development of melanoma is often centered on cellular signaling that hyper-activates survival pathways, while inducing a conco...
Autores principales: | Anvekar, Rina A., Asciolla, James J., Missert, Derek J., Chipuk, Jerry E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260552/ https://www.ncbi.nlm.nih.gov/pubmed/22268005 http://dx.doi.org/10.3389/fonc.2011.00034 |
Ejemplares similares
-
Sensitization to the mitochondrial pathway of apoptosis augments melanoma tumor cell responses to conventional chemotherapeutic regimens
por: Anvekar, R A, et al.
Publicado: (2012) -
Anti-apoptotic BCL-2 proteins govern cellular outcome following B-RAF(V600E) inhibition and can be targeted to reduce resistance
por: Serasinghe, Madhavika N., et al.
Publicado: (2014) -
BCL-2 proteins: melanoma lives on the edge
por: Chipuk, Jerry Edward
Publicado: (2015) -
The peroxisomes strike BAK: Regulation of peroxisome integrity by the Bcl-2 family
por: Chipuk, Jerry Edward, et al.
Publicado: (2017) -
Craniotomy—The Child Born Alive
Publicado: (1850)